AIRVI COPD Interesting case studies and meaningful studies

Dr. Klaus Jung / Dr. phil. Dinah Jung (2014) Handbook on Somatovital Therapy Part II: Studies and Practical Experience - Monsenstein and Vannerdat

• COPD with pulmonary emphysema, paO2 approx. 50 mmHg, durationO2 therapy so far rejected due to relatively good subjective state of health, partial improvement after acupuncture, skeptical attitude towards spirovitalisation, beginning with 3 x 10 or later 3 x 15 min daily, 3 x/ week, despite unfavourable weather conditions clear improvement of subjective state of health, increase of paO2 rather low up to 54 mmHg, overall positive assessment.
• Clinical diagnosis: Infection-acerbated COPD with pulmonary emphysema, increased formation of viscous mucus which is difficult to cough up, nocturnal coughing attacks, after spirovitalisation (1 x 21 min daily) easier coughing up of much and more liquid mucus, freer breathing.
• COPD with pulmonary emphysema, 71 a, severe worsening in recent years, most recently increasing shortness of breath, specialist treatment, severe setback after a cold (damp and cold weather), immediate improvement after spirovitalization (no shortness of breath any more, walking and climbing stairs again possible).
• COPD since approx. 12 a, side effects due to drug therapy (stomach, eyes), already after the first Spirovital application clear subjective and objective improvement (well-being, activity, less medication, especially prednisone reduction, no more exacerbations, no more colds, clear increase in oxygen saturation).
• COPD due to smoking and occupational exposure to asbestos, 55 a, shortness of breath, lack of energy, walking distance 25 m, no longer able to walk, significant improvement (more air, more energy) just a few days after the start of spirovitalization, increase in paO2 from below 70 to over 90 mmHg, improvement in lung function, even 1 a later no relapse, overall significant improvement (in the work process, on the home trainer, in terms of physical and mental performance).
• COPD, 66 a, in specialist treatment since 5 a, no more colds since spirovitalisation, more energy, better subjective well-being, increased oxygen content in the blood, less coughing, easier walking.
• COPD, 59 a, after spirovitalization short-term deterioration of subjective state, afterwards "amazing" improvement (climbing stairs without shortness of breath, increase of energy level, better sleep, no more fatigue).
• COPD, 78 a, heavy smoker life-long, before 4 a after pneumonia strong deterioration of subjective and objective well-being (COPD), inhaler prescription, further deterioration to total immobility, after spirovitalization continuous increase of FEV1 from 0.59 l to 0.80 l and FVC from 1.86 l to more than 3.10 l (increase of 210 and 1,150 ml, respectively). Thereby significant increase of subjective well-being and performance.
• COPD, 65 a, constant mucus, additional osteoporosis, rheumatoid arthritis, osteoarthritis; maximum walking distance approx. 200 m, shortness of breath, no appetite; since Spirovital use reduction of inhaler applications, increase of peak flow (PEF) from 200 to 300 l/min, regular participation in lung sports without problems, more energy, more endurance, no shortness of breath anymore, improvement of blood circulation, easier coughing up of liquid mucus, improvement of sleep, more self-confidence, better well-being.